10-Q Filing

BNB PLUS CORP. CIK: 744452 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001104659-21-065932`
Period End Date	20210331
Filing Date	20210513
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	apdn-20210331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 76 Cash Flow Statement 74 Stockholders Equity 40

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$11.97K	USD	Point-in-time
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$20.83K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.79M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.93M	USD	Point-in-time
Accounts receivable, net of allowance of $20,830 and $11,968 at March 31, 2021 and September 30, 2020, respectively	`AccountsReceivableNetCurrent`	$194.32K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $20,830 and $11,968 at March 31, 2021 and September 30, 2020, respectively	`AccountsReceivableNetCurrent`	$2.19M	USD	Point-in-time
Inventories	`InventoryNet`	$497.37K	USD	Point-in-time
Inventories	`InventoryNet`	$720.54K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$586.21K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$599.30K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.08M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$17.42M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.28M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.42M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.14M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.04K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.08K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$605.33K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$559.35K	USD	Point-in-time
Total Assets	`Assets`	$20.78M	USD	Point-in-time
Total Assets	`Assets`	$11.34M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.93M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.78M	USD	Point-in-time
Promissory notes payable-current portion	`NotesPayableToBankCurrent`	$329.30K	USD	Point-in-time
Secured convertible notes payable, net of debt issuance costs	`ConvertibleNotesPayableCurrent`	$1.50M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$511.04K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$350.06K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.13M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$848.31K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Promissory notes payable-long term portion	`NotesPayableToBankNoncurrent`	$517.49K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.16M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.63M	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2021 and September 30, 2020, 7,486,120 and 5,142,779 shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively	`CommonStockValue`	$7.49K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2021 and September 30, 2020, 7,486,120 and 5,142,779 shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively	`CommonStockValue`	$5.14K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$294.78M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$275.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-276.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-269.84M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity:	`StockholdersEquity`	$5.72M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity:	`StockholdersEquity`	$18.63M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-6.51K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-8.72K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.62M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$11.34M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$20.78M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.19M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$552.47K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.67M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.29M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$179.58K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$599.17K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$356.61K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$411.61K	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.66M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.29M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.56M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.06M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.62M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$703.02K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.27M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$874.05K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$141.60K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$296.79K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$66.54K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$199.38K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.06M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.07M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$8.98M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$4.63M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.32M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.68M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-5.29M	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-5.29M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$8.40K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-29.10K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-58.19K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$13.84K	USD	1 Quarter
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	$-1.77M	USD	2 Qtrs
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	$839.95K	USD	2 Qtrs
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	$839.95K	USD	1 Quarter
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	-	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-239.60K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-54.87K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-261.83K	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-108.73K	USD	2 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.32M	USD	2 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.95M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.61M	USD	2 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.52M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.52M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.95M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.66M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-5.61M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-4.81M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-6.32M	USD	2 Qtrs
Less: Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-278.00	USD	1 Quarter
Less: Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.22K	USD	1 Quarter
Less: Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.19K	USD	2 Qtrs
Less: Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.22K	USD	2 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-5.61M	USD	2 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-1.52M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-6.33M	USD	2 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-2.95M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$-2.84K	USD	2 Qtrs
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.33M	USD	2 Qtrs
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.95M	USD	1 Quarter
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.62M	USD	2 Qtrs
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.52M	USD	1 Quarter
Net loss per share applicable to common stockholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.79	USD	1 Quarter
Net loss per share applicable to common stockholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.00	USD	2 Qtrs
Net loss per share applicable to common stockholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.76	USD	2 Qtrs
Net loss per share applicable to common stockholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.24M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.20M	shares	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.34M	shares	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.76M	shares	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.52M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.61M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.81M	USD	1 Quarter
Net loss	`ProfitLoss`	$-6.32M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$296.79K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$141.60K	USD	2 Qtrs
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	$-1.77M	USD	2 Qtrs
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	$839.95K	USD	2 Qtrs
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	$839.95K	USD	1 Quarter
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.22M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$432.76K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$12.58K	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	-	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$19.64K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.01M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-290.83K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$223.17K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-53.69K	USD	2 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-13.09K	USD	2 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$87.11K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.19M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-424.63K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-160.98K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$42.53K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.43M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.15M	USD	2 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	$36.52K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.14M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.23K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-44.75K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.14M	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$2.61M	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$2.77M	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.10M	USD	Point-in-time
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$10.64M	USD	2 Qtrs
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$13.76M	USD	2 Qtrs
Repayment of secured convertible notes payable	`RepaymentsOfConvertibleDebt`	$1.67M	USD	2 Qtrs
Repayment of secured convertible notes payable	`RepaymentsOfConvertibleDebt`	$107.80K	USD	2 Qtrs
Capitalized offering costs	`CapitalizedOfferingCostsClassifiedAsFinancingActivities`	-	USD	2 Qtrs
Capitalized offering costs	`CapitalizedOfferingCostsClassifiedAsFinancingActivities`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.30M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.70M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.14M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.10M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.66M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.66M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash paid during period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Interest paid in kind	`PaidInKindInterest`	$28.33K	USD	2 Qtrs
Interest paid in kind	`PaidInKindInterest`	$35.62K	USD	2 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$109.42K	USD	2 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$256.19K	USD	2 Qtrs
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	$2.84K	USD	2 Qtrs
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	-	USD	2 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	-	USD	2 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	$1.07M	USD	2 Qtrs
Deferred offering costs reclassified to accounts payable	`ReclassificationOfDeferredOfferingCostToAccountsPayable`	$109.70K	USD	2 Qtrs
Deferred offering costs reclassified to accounts payable	`ReclassificationOfDeferredOfferingCostToAccountsPayable`	-	USD	2 Qtrs
Intangible asset costs incurred, and included in accounts payable	`IntangibleAssetCostsIncurredAndIncludedInAccountsPayable`	-	USD	2 Qtrs
Intangible asset costs incurred, and included in accounts payable	`IntangibleAssetCostsIncurredAndIncludedInAccountsPayable`	$14.38K	USD	2 Qtrs

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.62M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-13.76M	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-10.53M	USD	1 Quarter
Common stock issued in public offering, net of offering costs (in shares)	`SharesIssuedInPublicOfferingShares`	2.29M	shares	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$-8.40K	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$2.77M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$-2.61M	USD	1 Quarter
Exercise of warrants (in shares)	`StockIssuedDuringPeriodValueWarrantsExercisedShare`	566,950.00	shares	1 Quarter
Fair value of warrants issued in connection with convertible note repayment	`WarrantsIssuedDuringPeriodValueWarrants`	$1.64M	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$649.25K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$227.27K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$571.50K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$205.49K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.52M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.61M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.81M	USD	1 Quarter
Net loss	`ProfitLoss`	$-6.32M	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.62M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.